Netea, S.A.; Biesbroek, G.; van Stijn, D.; Nagelkerke, S.Q.; Kawasaki Study Group; CAHAL Group; KIRI Group; Kuipers, I.M.; Kuijpers, T.W.
Kawasaki Disease Diagnosis and Treatment in over 1000 Patients: A Continuum of Dysregulated Inflammatory Responses. Biomedicines 2024, 12, 2014.
https://doi.org/10.3390/biomedicines12092014
AMA Style
Netea SA, Biesbroek G, van Stijn D, Nagelkerke SQ, Kawasaki Study Group, CAHAL Group, KIRI Group, Kuipers IM, Kuijpers TW.
Kawasaki Disease Diagnosis and Treatment in over 1000 Patients: A Continuum of Dysregulated Inflammatory Responses. Biomedicines. 2024; 12(9):2014.
https://doi.org/10.3390/biomedicines12092014
Chicago/Turabian Style
Netea, Stejara A., Giske Biesbroek, Diana van Stijn, Sietse Q. Nagelkerke, Kawasaki Study Group, CAHAL Group, KIRI Group, Irene M. Kuipers, and Taco W. Kuijpers.
2024. "Kawasaki Disease Diagnosis and Treatment in over 1000 Patients: A Continuum of Dysregulated Inflammatory Responses" Biomedicines 12, no. 9: 2014.
https://doi.org/10.3390/biomedicines12092014
APA Style
Netea, S. A., Biesbroek, G., van Stijn, D., Nagelkerke, S. Q., Kawasaki Study Group, CAHAL Group, KIRI Group, Kuipers, I. M., & Kuijpers, T. W.
(2024). Kawasaki Disease Diagnosis and Treatment in over 1000 Patients: A Continuum of Dysregulated Inflammatory Responses. Biomedicines, 12(9), 2014.
https://doi.org/10.3390/biomedicines12092014
